Nuvaxovid 2025-2026 Formula now approved in Japan triggering Takeda milestone payment – Novavax
Novavax Inc. announced a milestone payment from Takeda has been triggered by regulatory approval in Japan for Novavax’s Covid-19 vaccine Nuvaxovid 2025-2026 Formula (Intramuscular Injection 1 mL) formulated… read more.




